Findings

What do systematic reviews say?

6 questions · 7 findings · 1 reviews

No studies found 3 · 42.9%GRADE not reported 0 · 0%Very low 4 · 57.1%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Treatment discontinuation · men with Peyronie's disease (stable phase)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment discontinuation · men with Peyronie's disease (palpable plaque or pain)

The review found no eligible studies for this question.

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Treatment discontinuation · men with chronic Peyronie's disease (plaques without calcification)

It is very uncertain whether injectional nicardipine changes discontinuation from treatment compared with saline (very low certainty).

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
RR 0.71 [0.25, 2.05]
1 study · 74 participants
Very low

Treatment discontinuation · men with Peyronie's disease (diagnosis of disease: at least 12 months, penile curvature: at least 30 degrees)

The review found no eligible studies for this question.

2 findings from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found
Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
RR 1.25 [0.84, 1.86]
1 study · 836 participants
Very low

Treatment discontinuation · men with Peyronie's disease (not defined)

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Treatment discontinuation · men with chronic (≥ 12 months) Peyronie's disease (single plaque)

It is very uncertain whether injectional interferon alpha‐2B changes discontinuation from treatment compared with saline (very low certainty).

1 finding from 1 review

Non‐surgical therapies for Peyronie's disease 2023 · Cochrane Headline outcomes only
RR 0.63 [0.22, 1.76]
1 study · 117 participants
Very low